Illumina CEO on Genomic Sequencing Opportunities and AIWritten by BloombergPublished Jul 31, 2026, 8:51 PMWatch on Grafa TVShareIllumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close."